What is medical communications in pharma?

Medical communications transforms complex clinical and scientific data into clear, accurate, and engaging content for healthcare professionals, patients, and stakeholders. This includes publication planning, medical writing, congress materials, KOL engagement, and educational content that supports evidence-based decision-making throughout the product lifecycle.

When should we start publication planning?

Publication planning should ideally begin during Phase 2 clinical trials, allowing sufficient time to develop a strategic approach to disseminating clinical data. Early planning ensures optimal timing for manuscript submissions, congress presentations, and ensures your evidence reaches the right audiences at critical decision points.

How does Petauri Advance differ from other medical communications agencies?

Petauri Advance operates through a network of specialized independent agencies (Bluprint Oncology, Verascity Science, Cogency, DRIVE, MOMENTUM, and Propel), each bringing deep therapeutic area expertise. This structure allows us to combine the agility and specialization of boutique agencies with the resources and integrated capabilities of a larger organization.

What deliverables can we expect from a medical communications engagement?

Typical deliverables include publication plans, peer-reviewed manuscripts, congress abstracts and posters, slide decks, scientific platforms and lexicons, medical affairs training materials, digital and creative assets, KOL engagement strategies, and both branded and unbranded content for various stakeholder audiences.

Medical Communications & Scientific Affairs

Q: What therapeutic areas does Petauri Advance specialize in?

Petauri Advance has specialized expertise in oncology and hematology (Bluprint), rare disease and complex mechanisms of action (Verascity), cardiometabolic health, neuroscience, and immunology (DRIVE), and emerging therapeutic areas (Propel). Our network approach ensures deep clinical knowledge across diverse disease states.

Home › Petauri Advance

Turning breakthrough science into impact

Medical and Scientific Communications

Precision in the science. Power in the delivery.

Petauri Advance harnesses decades of specialized experience through our network of independent agencies, guiding biopharma and device companies through the intricacies of today’s healthcare landscape.

Grounded in scientific expertise, we deliver innovative medical communication strategies that transform evidence into understanding, which in turn empowers informed decisions and advances patient care

From insights and expert engagement to digital delivery, we turn science into action

Start a project

Our Agencies

Six Agencies. One Advance.

Independent excellence, delivering science‑anchored communications at scale

Integrated strategies, engagement, and education for oncology and hematology

Creative and digital communications and engagement for rare disease and complex MOAs

Subscription-based actionable insight generation through real-world expert and community engagement

Integrated strategies, engagement, and HCP education for cardiometabolic health, neuroscience, and immunology

Scientific communication strategies, engagement, and HCP education solutions through live and virtual interactions

Strategic innovation, insight-driven engagement, and HCP education tailored to emerging therapeutic areas and evolving healthcare landscapes

Capabilities & Services

Strategy‑led. Science‑backed. Execution‑driven.

Strategic Planning & Launch Preparedness

Position products for success

From early development through commercialization, we partner with you to ensure every launch is informed, aligned, and primed for market impact.

We leverage insights to interpret complex data, assess landscapes, and collaborate with key stakeholders to establish and communicate your scientific foundation and evidence for innovation readiness.

Scientific Communications

Translate the science of medicine

Our expertise transforms complex science into clear, compelling narratives that inform clinicians and drive better patient care.

We excel in crafting disease, asset, and brand communications that span the entire product life cycle. With our tailored approach, your scientific evidence is not only understood but also valued and acted upon.

Experiential Medical Education and Promotional Activities

Bridge the gap between data and clinical application

We bring science to life by crafting engaging content and immersive learning experiences, harnessing cutting-edge technologies to inspire action and create transformative impact.

We deliver exceptional live, virtual, and digital experiences using advanced technologies designed to engage, empower, and change behaviors.

Expert Engagement and Insights

Strategically engage HCPs for insights and impact

Adopting a strategic approach to how, what, and when to engage HCPs across all phases of an asset–early and consistently–is essential.

Effective engagement not only differentiates a company from its competitors but also nurtures ongoing KOL interactions, positioning the company as a prominent industry leader.